• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与去铁胺偶联的线粒体穿透肽作为线粒体不稳定铁的螯合剂

Mitochondria-penetrating peptides conjugated to desferrioxamine as chelators for mitochondrial labile iron.

作者信息

Alta Roxana Y P, Vitorino Hector A, Goswami Dibakar, Liria Cleber W, Wisnovsky Simon P, Kelley Shana O, Machini M Terêsa, Espósito Breno P

机构信息

Department of Fundamental Chemistry, Institute of Chemistry, University of São Paulo, São Paulo, Brazil.

Department of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, Brazil.

出版信息

PLoS One. 2017 Feb 8;12(2):e0171729. doi: 10.1371/journal.pone.0171729. eCollection 2017.

DOI:10.1371/journal.pone.0171729
PMID:28178347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5298241/
Abstract

Desferrioxamine (DFO) is a bacterial siderophore with a high affinity for iron, but low cell penetration. As part of our ongoing project focused on DFO-conjugates, we synthesized, purified, characterized and studied new mtDFOs (DFO conjugated to the Mitochondria Penetrating Peptides TAT49-57, 1A, SS02 and SS20) using a succinic linker. These new conjugates retained their strong iron binding ability and antioxidant capacity. They were relatively non toxic to A2780 cells (IC50 40-100 μM) and had good mitochondrial localization (Rr +0.45 -+0.68) as observed when labeled with carboxy-tetramethylrhodamine (TAMRA) In general, mtDFO caused only modest levels of mitochondrial DNA (mtDNA) damage. DFO-SS02 retained the antioxidant ability of the parent peptide, shown by the inhibition of mitochondrial superoxide formation. None of the compounds displayed cell cycle arrest or enhanced apoptosis. Taken together, these results indicate that mtDFO could be promising compounds for amelioration of the disease symptoms of iron overload in mitochondria.

摘要

去铁胺(DFO)是一种对铁具有高亲和力但细胞穿透性低的细菌铁载体。作为我们正在进行的专注于DFO缀合物项目的一部分,我们使用琥珀酸接头合成、纯化、表征并研究了新的线粒体靶向去铁胺(mtDFO,即与线粒体穿透肽TAT49 - 57、1A、SS02和SS20缀合的DFO)。这些新的缀合物保留了其强大的铁结合能力和抗氧化能力。它们对A2780细胞相对无毒(IC50为40 - 100 μM),并且在用羧基四甲基罗丹明(TAMRA)标记时显示出良好的线粒体定位(Rr为 +0.45 - +0.68)。总体而言,mtDFO仅引起适度水平的线粒体DNA(mtDNA)损伤。DFO - SS02保留了母体肽的抗氧化能力,这通过抑制线粒体超氧化物的形成得以体现。这些化合物均未表现出细胞周期停滞或增强的细胞凋亡。综上所述,这些结果表明mtDFO可能是改善线粒体铁过载疾病症状的有前景的化合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f96/5298241/df5cbea3dc9b/pone.0171729.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f96/5298241/9cb481a50e34/pone.0171729.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f96/5298241/5f612dbb4b0e/pone.0171729.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f96/5298241/b5e51c643849/pone.0171729.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f96/5298241/92baf96e5c9d/pone.0171729.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f96/5298241/df5cbea3dc9b/pone.0171729.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f96/5298241/9cb481a50e34/pone.0171729.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f96/5298241/5f612dbb4b0e/pone.0171729.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f96/5298241/b5e51c643849/pone.0171729.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f96/5298241/92baf96e5c9d/pone.0171729.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f96/5298241/df5cbea3dc9b/pone.0171729.g005.jpg

相似文献

1
Mitochondria-penetrating peptides conjugated to desferrioxamine as chelators for mitochondrial labile iron.与去铁胺偶联的线粒体穿透肽作为线粒体不稳定铁的螯合剂
PLoS One. 2017 Feb 8;12(2):e0171729. doi: 10.1371/journal.pone.0171729. eCollection 2017.
2
Triphenylphosphonium-desferrioxamine as a candidate mitochondrial iron chelator.三苯基膦-去铁胺作为候选线粒体铁螯合剂。
Biometals. 2017 Oct;30(5):709-718. doi: 10.1007/s10534-017-0039-5. Epub 2017 Aug 2.
3
Cell penetrating peptide (CPP)-conjugated desferrioxamine for enhanced neuroprotection: synthesis and in vitro evaluation.用于增强神经保护作用的细胞穿透肽(CPP)偶联去铁胺:合成与体外评价
Bioconjug Chem. 2014 Nov 19;25(11):2067-80. doi: 10.1021/bc5004197. Epub 2014 Oct 20.
4
Conjugates of desferrioxamine and aromatic amines improve markers of iron-dependent neurotoxicity.去铁胺与芳香胺的缀合物可改善铁依赖性神经毒性的标志物。
Biometals. 2021 Apr;34(2):259-275. doi: 10.1007/s10534-020-00277-7. Epub 2021 Jan 3.
5
In vitro chelating, cytotoxicity, and blood compatibility of degradable poly(ethylene glycol)-based macromolecular iron chelators.可降解聚乙二醇基大分子铁螯合剂的体外螯合、细胞毒性及血液相容性
Biomaterials. 2009 Feb;30(4):638-48. doi: 10.1016/j.biomaterials.2008.09.057. Epub 2008 Nov 1.
6
Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine.用与去铁胺偶联的亲水嵌段共聚物进行铁螯合癌症治疗。
Cancer Sci. 2021 Jan;112(1):410-421. doi: 10.1111/cas.14607. Epub 2020 Nov 29.
7
Iron Binding and Iron Removal Efficiency of Desferrioxamine Based Polymeric Iron Chelators: Influence of Molecular Size and Chelator Density.基于去铁胺的聚合铁螯合剂的铁结合与铁去除效率:分子大小和螯合剂密度的影响
Macromol Biosci. 2017 Mar;17(3). doi: 10.1002/mabi.201600244. Epub 2016 Sep 28.
8
Novel trihydroxamate-containing peptides: design, synthesis, and metal coordination.含新型三异羟肟酸的肽:设计、合成与金属配位
Biopolymers. 2006;84(5):472-89. doi: 10.1002/bip.20532.
9
Desferrioxamine-caffeine (DFCAF) as a cell permeant moderator of the oxidative stress caused by iron overload.去铁胺-咖啡因(DFCAF)作为铁过载引起的氧化应激的细胞渗透调节剂。
Biometals. 2014 Dec;27(6):1351-60. doi: 10.1007/s10534-014-9795-7. Epub 2014 Sep 30.
10
Prevention of oxidant-induced cell death by lysosomotropic iron chelators.溶酶体促效铁螯合剂对氧化剂诱导的细胞死亡的预防作用
Free Radic Biol Med. 2003 May 15;34(10):1295-305. doi: 10.1016/s0891-5849(03)00106-0.

引用本文的文献

1
Iron chelators: as therapeutic agents in diseases.铁螯合剂:作为疾病治疗药物
Ann Med Surg (Lond). 2024 Mar 19;86(5):2759-2776. doi: 10.1097/MS9.0000000000001717. eCollection 2024 May.
2
Structure-activity relationships of mitochondria-targeted tetrapeptide pharmacological compounds.靶向线粒体的四肽药理化合物的构效关系。
Elife. 2022 Aug 1;11:e75531. doi: 10.7554/eLife.75531.
3
The synthesis and properties of mitochondrial targeted iron chelators.线粒体靶向铁螯合剂的合成与性质。

本文引用的文献

1
Iron chelation in the treatment of neurodegenerative diseases.铁螯合疗法在神经退行性疾病治疗中的应用。
J Trace Elem Med Biol. 2016 Dec;38:81-92. doi: 10.1016/j.jtemb.2016.03.010. Epub 2016 Mar 24.
2
Deferasirox-TAT(47-57) peptide conjugate as a water soluble, bifunctional iron chelator with potential use in neuromedicine.去铁胺-转铁蛋白(47-57)肽偶联物作为一种水溶性双功能铁螯合剂,在神经医学中有潜在应用。
Biometals. 2015 Oct;28(5):869-77. doi: 10.1007/s10534-015-9873-5. Epub 2015 Jul 12.
3
Mitochondrial Targeting of Doxorubicin Eliminates Nuclear Effects Associated with Cardiotoxicity.
Biometals. 2023 Apr;36(2):321-337. doi: 10.1007/s10534-022-00383-8. Epub 2022 Apr 2.
4
Smart Stimuli-Responsive and Mitochondria Targeting Delivery in Cancer Therapy.智能刺激响应和线粒体靶向递药在癌症治疗中的应用。
Int J Nanomedicine. 2021 Jun 15;16:4117-4146. doi: 10.2147/IJN.S315368. eCollection 2021.
5
Emerging insights into mitochondria-specific targeting and drug delivering strategies: Recent milestones and therapeutic implications.线粒体特异性靶向与药物递送策略的新见解:近期进展与治疗意义
Saudi J Biol Sci. 2020 Dec;27(12):3581-3592. doi: 10.1016/j.sjbs.2020.07.030. Epub 2020 Aug 1.
6
Enterobactin induces the chemokine, interleukin-8, from intestinal epithelia by chelating intracellular iron.肠菌素通过螯合细胞内铁诱导肠道上皮细胞产生趋化因子白细胞介素-8。
Gut Microbes. 2020 Nov 9;12(1):1-18. doi: 10.1080/19490976.2020.1841548.
7
Enterobactin, an iron chelating bacterial siderophore, arrests cancer cell proliferation.铁载体依沙菌素通过螯合铁来抑制癌细胞的增殖。
Biochem Pharmacol. 2019 Oct;168:71-81. doi: 10.1016/j.bcp.2019.06.017. Epub 2019 Jun 19.
8
Overcoming chemotherapy resistance simultaneous drug-efflux circumvention and mitochondrial targeting.克服化疗耐药性:同时规避药物外排和靶向线粒体
Acta Pharm Sin B. 2019 May;9(3):615-625. doi: 10.1016/j.apsb.2018.11.005. Epub 2018 Nov 29.
9
Mitochondrial Iron in Human Health and Disease.线粒体铁在人类健康和疾病中的作用
Annu Rev Physiol. 2019 Feb 10;81:453-482. doi: 10.1146/annurev-physiol-020518-114742. Epub 2018 Nov 28.
10
Fluorescent and Photosensitizing Conjugates of Cell-Penetrating Peptide TAT(47-57): Design, Microwave-Assisted Synthesis at 60 °C, and Properties.细胞穿透肽TAT(47 - 57)的荧光和光敏共轭物:设计、60℃下的微波辅助合成及其性质
ACS Omega. 2017 Nov 30;2(11):8156-8166. doi: 10.1021/acsomega.7b01127. Epub 2017 Nov 20.
阿霉素的线粒体靶向作用消除了与心脏毒性相关的核效应。
ACS Chem Biol. 2015 Sep 18;10(9):2007-15. doi: 10.1021/acschembio.5b00268. Epub 2015 Jun 18.
4
Cell penetrating peptide (CPP)-conjugated desferrioxamine for enhanced neuroprotection: synthesis and in vitro evaluation.用于增强神经保护作用的细胞穿透肽(CPP)偶联去铁胺:合成与体外评价
Bioconjug Chem. 2014 Nov 19;25(11):2067-80. doi: 10.1021/bc5004197. Epub 2014 Oct 20.
5
Mitochondrial metals as a potential therapeutic target in neurodegeneration.线粒体金属作为神经退行性疾病的潜在治疗靶点。
Br J Pharmacol. 2014 Apr;171(8):2159-73. doi: 10.1111/bph.12513.
6
Targeting mitochondrial DNA with a platinum-based anticancer agent.用一种铂类抗癌剂靶向线粒体DNA。
Chem Biol. 2013 Nov 21;20(11):1323-8. doi: 10.1016/j.chembiol.2013.08.010. Epub 2013 Oct 31.
7
Targeted delivery of doxorubicin to mitochondria.阿霉素向线粒体的靶向递送。
ACS Chem Biol. 2013 Jul 19;8(7):1389-95. doi: 10.1021/cb400095v. Epub 2013 Apr 23.
8
Re-directing an alkylating agent to mitochondria alters drug target and cell death mechanism.将烷化剂重定向到线粒体会改变药物靶点和细胞死亡机制。
PLoS One. 2013 Apr 9;8(4):e60253. doi: 10.1371/journal.pone.0060253. Print 2013.
9
Therapeutic developments in Friedreich ataxia.弗里德赖希共济失调的治疗进展
J Child Neurol. 2012 Sep;27(9):1212-6. doi: 10.1177/0883073812449691. Epub 2012 Jul 12.
10
Real-world use of iron chelators.铁螯合剂的实际应用。
Hematology Am Soc Hematol Educ Program. 2011;2011:451-8. doi: 10.1182/asheducation-2011.1.451.